Smoking Cessation Counseling for Pregnancy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help pregnant women quit smoking through text message support and training for their obstetricians. Women who smoke and are attending their first OB visit at Duke or Pitt may qualify. The trial will compare the effectiveness of personalized communication training for doctors (Clinician Communication Intervention) with standard smoking cessation lectures (5A's lecture). Participants will receive supportive text messages throughout their pregnancy to aid in quitting smoking. The study will evaluate how well these strategies improve smoking cessation rates. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance support for pregnant women trying to quit smoking.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this method is safe for pregnant patients?
Research has shown that behavioral counseling is a safe and effective method to help pregnant women quit smoking. Studies indicate that counseling, especially when tailored for pregnant women, can assist them in stopping tobacco use with minimal risk.
The Clinician Communication Intervention under study is considered low risk, expected to be safe and manageable. This intervention trains healthcare providers to offer improved advice on quitting smoking, which has helped many pregnant women quit.
No evidence suggests harmful side effects from this type of intervention. In fact, similar counseling methods have been widely used and supported by numerous studies. These studies emphasize that counseling during pregnancy is not only safe but also crucial for the health of both the mother and baby.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a new way to help pregnant individuals quit smoking through improved communication. Unlike standard smoking cessation methods that primarily focus on nicotine replacement or medication, this intervention enhances how clinicians communicate, providing them with specialized training. This tailored communication approach aims to make smoking cessation advice more relatable and effective for pregnant patients, potentially leading to better outcomes for both mother and child. By focusing on clinician-patient interactions, the trial could revolutionize how smoking cessation is approached during pregnancy, offering a fresh perspective beyond traditional methods.
What evidence suggests that this trial's treatments could be effective for smoking cessation during pregnancy?
Research shows that special communication training for doctors can significantly help pregnant women quit smoking. In this trial, clinicians in the intervention arm will receive tailored communication training on smoking cessation skills. Studies have shown that this training can increase quit rates by 30-70% for pregnant smokers. The 5As model—asking about smoking, advising to quit, assessing readiness, assisting with quitting, and arranging follow-up—has also proven effective. Clinicians in the control arm will attend a lecture on general information about smoking cessation for pregnant patients. Counseling specifically designed for pregnant women has shown even better results. While counseling and materials tailored for pregnant women have been helpful, some women may still find it challenging to quit. Overall, these methods have strong potential to help pregnant women stop smoking.13567
Who Is on the Research Team?
Kathryn I Pollak, PhD
Principal Investigator
Duke University
Are You a Good Fit for This Trial?
This trial is for pregnant women over 18 who smoke and are getting prenatal care from a participating OB clinician. They must have smoked tobacco at their first OB visit, be able to speak and read English, and have access to a cell phone that can send texts.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-Intervention
Collection of pre-intervention audio-recorded initial OB visit encounters to assess clinician communication skills
Intervention
OB clinicians receive tailored training on smoking cessation skills; patients receive SMS smoking cessation messages
Post-Intervention
Assessment of the effect of the communication program by audio recording initial OB visits and surveying patients
Follow-up
Participants are monitored for smoking cessation outcomes and surveyed at 6 weeks postpartum
What Are the Treatments Tested in This Trial?
Interventions
- 5A's lecture
- Clinician Communication Intervention
Clinician Communication Intervention is already approved in United States, European Union, Canada for the following indications:
- Smoking cessation in pregnant women
- Smoking cessation in pregnant women
- General smoking cessation
- Smoking cessation in pregnant women
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
University of Pittsburgh
Collaborator